Home
Scholarly Works
Impact of rolapitant on quality of life (QoL) in...
Conference

Impact of rolapitant on quality of life (QoL) in patients (pts) receiving highly emetogenic chemotherapy (HEC) and moderately emetogenic chemotherapy (MEC)

Authors

Chasen M; Urban L; Schnadig I; Rapoport BL; Poma A; Arora S; Navari RM; Schwartzberg LS; Gridelli C

Volume

33

Publisher

AMER SOC CLINICAL ONCOLOGY

Publication Date

May 20, 2015

Name of conference

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer

Conference place

Chicago, IL

Conference start date

May 29, 2015

Conference end date

June 2, 2015

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

15

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team